Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-01Clinical Trial Update: Methylphenidate and a Nursing Telephone Intervention for Fatigue [Phase 2, Phase 3]
Phase 2/Phase 3 trial update evaluating methylphenidate plus a nursing telephone intervention for fatigue in advanced cancer patients; study…
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy [Phase 4]
Phase 4 trial evaluating the impact of edoxaban for cancer-associated venous thromboembolism during antineoplastic therapy has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer [Phase 1]
Phase 1 study assessing potential drug-drug interactions between rifampin or itraconazole and pamiparib in cancer patients; study completed …
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Prospective Randomized Open Label Study of the Treatment of Therapy-associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - [Phase 3]
A randomized phase 3 trial evaluating loperamide versus tincture of opium for therapy-associated diarrhea during pelvic radiotherapy has bee…
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 trial evaluating whether adding olanzapine to fosaprepitant dimeglumine improves prevention of chemotherapy-induced nausea and vomit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies [Phase 1, Phase 2]
Pfizer's PD-1 inhibitor sasanlimab (PF-06801591) is being studied in Phase 1/2 in adults with advanced cancers, including non-small-cell lun…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: CHildren Treated With Vincristine: A Trial Regarding Pharmacokinetics, DNA And Toxicity of Targeted Therapy In Pediatric Oncology Patients. [Phase 4]
Phase 4 clinical trial update investigating pharmacokinetics, DNA effects, and toxicity of a targeted therapy in pediatric cancer patients t…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib [Phase 2]
Phase 2 clinical trial update on continuing treatment for subjects who participated in a prior protocol investigating dasatinib; results pos…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity [Phase 1, Phase 2]
Clinical trial update evaluating memantine for prevention of oxaliplatin-induced peripheral neurotoxicity in cancer patients (Phase 1/Phase …
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for BMS-863233 in advanced and/or metastatic solid tumors (Phase 1/2) with terminated status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Efficacy of Myofascial Pain Syndrome Treatment in Patients With Cancer in Palliative Care [Phase 3]
Phase 3 trial update evaluating efficacy of a myofascial pain syndrome treatment in cancer patients receiving palliative care has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Motivating a Spectrum of Cancer Patients to Quit Smoking [NA]
Clinical trial update on motivating cancer patients who smoke to quit smoking; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making) [NA]
Completed clinical trial ACCESS studying caregiver education and support for shared decision making in cancer care; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects [Phase 2]
Phase 2 trial evaluating pamiparib in combination with tislelizumab for advanced tumors with homologous recombination repair defects; status…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A dose-escalation and combination immunotherapy trial evaluating BMS-986226 alone or with nivolumab or ipilimumab in advanced solid tumors w…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]
Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and uro…
-
EMA approval · 2023-02-24EMA Authorised: Aloxi (palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd.
Aloxi (palonosetron hydrochloride) has been authorised in the EU for use related to vomiting and cancer indications.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity [Phase 4]
Phase 4 clinical trial examining histamine H2 receptor antagonists as enhancers of anti-tumor immunity in cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients [Phase 3]
Phase 3 clinical trial investigating continuous erector spinae block for post-analgesia in pediatric cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating BBI608 in combination with paclitaxel in adult patients with advanced cancers has completed enrollment…
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating Lirilumab (anti-KIR) with Nivolumab (anti-PD-1) and the combination of Nivolumab plus Ipilimumab (anti-CTLA-4) …
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients. [Phase 2, Phase 3]
A clinical trial update for rectal dexmedetomidine niosomes assessing postoperative analgesia in pediatric cancer patients, currently in Pha…
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: The Menopause After Cancer Study [Phase 2]
Phase 2 clinical trial update for the Menopause After Cancer Study completed, investigating menopause-related symptoms in cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating INCAGN01876 in combination with immune therapies for advanced/metastatic cancers has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors [NA]
This clinical trial update reports results for a stress management and resiliency program designed for adolescent and young adult cancer sur…